“…Substance-use strategies include not sharing drug paraphernalia, or rinsing shared syringes and rigs in a bleach–water solution (Abdala, Crowe, Tostov, & Heimer, 2004; Abdala, Gleghorn, Carney, & Heimer, 2001; Cox, Lawless, Cassin, & Geoghegan, 2000; Koester, Glanz, & Baron, 2005; Richard, Mosier, & Atkinson, 2002). Sexual strategies include considering HIV status (serosorting) when deciding whether to share drug paraphernalia or to engage in condomless anal intercourse (CAS; Chen, Vallabhaneni, Raymond, & McFarland, 2012; Eaton, Kalichman, O’Connell, & Karchner, 2009; Philip, Yu, Donnell, Vittinghoff, & Buchbinder, 2010; Yang, Tobin, & Latkin, 2011; Zablotska et al, 2009), or using sexual positioning or withdrawal during CAS (Binson, Pollack, Blair, & Woods, 2010; Dubois-Arber, Jeannin, Lociciro, & Balthasar, 2012; Marks et al, 2010; McDaid & Hart, 2012; Parsons et al, 2005; Van de Ven et al, 2002). Biomedical strategies (i.e., pre- and post-exposure prophylaxis, and undetectable viral loads) to reduce HIV risk (Campbell, Herbst, Koppenhaver, & Smith, 2013) are not yet widely used among HIV–negative MSM (Krakower et al, 2012; Mutua et al, 2012), but their acceptability is increasing (Escudero et al, 2014; Holt, 2014; Young, Li, & McDaid, 2013; Young & McDaid, 2014).…”